Equal numbers of the OCP users and naturally menstruating elite females were considered to have an intermediate risk of cardiovascular disease (CRP 1–3 mg L−1), a result that may be due to the lack of standardization of the rested blood sample collection protocol. Here, CRP is linked to cardiovascular disorder.